Epidemiology of hepatitis B virus infection in people living in poverty in the central-west region of Brazil.
Adult
Age Factors
Biomarkers
Brazil
/ epidemiology
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay
Female
Hepatitis B
/ epidemiology
Hepatitis B Antibodies
Hepatitis B Surface Antigens
Hepatitis B virus
/ immunology
Humans
Male
Poverty
/ statistics & numerical data
Prevalence
Regression Analysis
Serologic Tests
Sex Factors
Sexual Behavior
Treponemal Infections
/ epidemiology
Young Adult
Epidemiology, immunisation
Hepatitis B infection
Poverty
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
29 Apr 2019
29 Apr 2019
Historique:
received:
26
11
2018
accepted:
15
04
2019
entrez:
1
5
2019
pubmed:
1
5
2019
medline:
10
7
2019
Statut:
epublish
Résumé
People living in poverty (PLP) are highly vulnerable to hepatitis B virus (HBV) infection. This study aimed to investigate the epidemiology of HBV infection in PLP in the metropolitan region of Goiânia, Goiás State, in the Central-West Region of Brazil. A cross-sectional study was conducted from August to December 2016 in adults aged ≥12 years living in poverty. The following serological markers for HBV were investigated: hepatitis B surface antigen (HBsAg), antibody to HBV core antigen (total anti-HBc), IgM anti-HBc, and hepatitis B surface antibody (anti-HBs), which were detected by enzyme-linked immunosorbent assay (ELISA). Poisson regression analysis with robust variance was performed to verify the factors associated with HBV exposure. The study included 378 participants. The overall prevalence rate of HBV (any viral marker) was 9.8% (95% confidence interval [CI], 7.2-13.2). The prevalence rate of HBsAg in combination with total anti-HBc was 0.8% (95% CI, 0.3-2.4), total anti-HBc in combination with anti-HBs was 7.7% (95% CI, 5.4-10.9), and total anti-HBc alone was 1.3% (95% CI, 0.5-3.0) in the population. Furthermore, isolated positivity for anti-HBs was identified in only 25.4% (95% CI, 21.3-30.0) of the participants. Multiple regression analysis revealed that age (adjusted prevalence ratio [APR], 1.04; 95% CI, 1.01-1.07), female sex (APR, 2.18; 95% CI, 1.01-4.73), sexual intercourse under the influence of alcohol (APR, 2.49; 95% CI, 1.36-7.06), and exposure to Treponema pallidum (APR, 3.10; 95% CI, 1.36-7.06) were associated with HBV exposure. There was a high prevalence of HBV exposure in PLP in the Central-West Region of Brazil, indicating significant viral spread of the infection. Additionally, there was low serological evidence of immunisation against hepatitis B, indicating that a large proportion of the participants in this study are susceptible to the infection. The results support the need for public health policies that facilitate access to the existing healthcare services in hard-to-reach groups with special regard to immunisation programmes against hepatitis B.
Sections du résumé
BACKGROUND
BACKGROUND
People living in poverty (PLP) are highly vulnerable to hepatitis B virus (HBV) infection. This study aimed to investigate the epidemiology of HBV infection in PLP in the metropolitan region of Goiânia, Goiás State, in the Central-West Region of Brazil.
METHODS
METHODS
A cross-sectional study was conducted from August to December 2016 in adults aged ≥12 years living in poverty. The following serological markers for HBV were investigated: hepatitis B surface antigen (HBsAg), antibody to HBV core antigen (total anti-HBc), IgM anti-HBc, and hepatitis B surface antibody (anti-HBs), which were detected by enzyme-linked immunosorbent assay (ELISA). Poisson regression analysis with robust variance was performed to verify the factors associated with HBV exposure.
RESULTS
RESULTS
The study included 378 participants. The overall prevalence rate of HBV (any viral marker) was 9.8% (95% confidence interval [CI], 7.2-13.2). The prevalence rate of HBsAg in combination with total anti-HBc was 0.8% (95% CI, 0.3-2.4), total anti-HBc in combination with anti-HBs was 7.7% (95% CI, 5.4-10.9), and total anti-HBc alone was 1.3% (95% CI, 0.5-3.0) in the population. Furthermore, isolated positivity for anti-HBs was identified in only 25.4% (95% CI, 21.3-30.0) of the participants. Multiple regression analysis revealed that age (adjusted prevalence ratio [APR], 1.04; 95% CI, 1.01-1.07), female sex (APR, 2.18; 95% CI, 1.01-4.73), sexual intercourse under the influence of alcohol (APR, 2.49; 95% CI, 1.36-7.06), and exposure to Treponema pallidum (APR, 3.10; 95% CI, 1.36-7.06) were associated with HBV exposure.
CONCLUSION
CONCLUSIONS
There was a high prevalence of HBV exposure in PLP in the Central-West Region of Brazil, indicating significant viral spread of the infection. Additionally, there was low serological evidence of immunisation against hepatitis B, indicating that a large proportion of the participants in this study are susceptible to the infection. The results support the need for public health policies that facilitate access to the existing healthcare services in hard-to-reach groups with special regard to immunisation programmes against hepatitis B.
Identifiants
pubmed: 31035990
doi: 10.1186/s12889-019-6828-8
pii: 10.1186/s12889-019-6828-8
pmc: PMC6489193
doi:
Substances chimiques
Biomarkers
0
Hepatitis B Antibodies
0
Hepatitis B Surface Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
443Subventions
Organisme : Programa de Extensão Universitária (ProExt)
ID : PROEXT 2016
Références
Vaccine. 2000 Feb 18;18 Suppl 1:S17-9
pubmed: 10683537
Epidemiology. 2002 Nov;13(6):707-12
pubmed: 12410013
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
Lancet Infect Dis. 2004 Jul;4(7):456-66
pubmed: 15219556
Epidemiol Rev. 2004;26:22-35
pubmed: 15234945
Mem Inst Oswaldo Cruz. 2006 May;101(3):251-6
pubmed: 16862317
Health Aff (Millwood). 2008 Mar-Apr;27(2):321-33
pubmed: 18332486
Rev Saude Publica. 2008 Oct;42(5):838-43
pubmed: 18695784
Rev Saude Publica. 2008 Dec;42(6):992-8
pubmed: 19009156
Am J Trop Med Hyg. 2009 Aug;81(2):240-7
pubmed: 19635877
Rev Saude Publica. 2009 Aug;43 Suppl 1:43-50
pubmed: 19669064
Arq Gastroenterol. 2010 Jan-Mar;47(1):35-41
pubmed: 20520973
J Natl Med Assoc. 2010 Sep;102(9):803-10
pubmed: 20922924
Ethn Dis. 2011 Summer;21(3):356-60
pubmed: 21942170
World J Hepatol. 2012 Mar 27;4(3):74-80
pubmed: 22489259
Am J Ind Med. 2012 Jul;55(7):650-5
pubmed: 22544469
Rev Panam Salud Publica. 2013 Oct;34(4):267-74
pubmed: 24301738
Rev Soc Bras Med Trop. 2014 Jan-Feb;47(1):18-23
pubmed: 24603732
Cien Saude Colet. 2014 Feb;19(2):333-42
pubmed: 24863810
Soc Sci Med. 2015 Sep;140:95-103
pubmed: 26210657
Lancet. 2015 Oct 17;386(10003):1546-55
pubmed: 26231459
J Clin Transl Hepatol. 2014 Dec;2(4):228-33
pubmed: 26356547
Am J Trop Med Hyg. 2015 Dec;93(6):1341-1348
pubmed: 26503280
Dan Med J. 2015 Dec;62(12):B5176
pubmed: 26621404
An Acad Bras Cienc. 2016 Sep;88(3):1549-55
pubmed: 27508989
Lancet Infect Dis. 2016 Dec;16(12):1399-1408
pubmed: 27638356
BMC Public Health. 2017 Jan 18;17(1):90
pubmed: 28100196
BMC Psychiatry. 2017 Mar 9;17(1):88
pubmed: 28274223
BMC Public Health. 2017 Jun 12;17(1):568
pubmed: 28606133
Cad Saude Publica. 2017 Aug 07;33(7):e00109216
pubmed: 28792993
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403
pubmed: 29599078
Lancet. 2018 Jun 2;391(10136):2236-2271
pubmed: 29893224
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
World J Gastroenterol. 2018 Nov 28;24(44):4959-4961
pubmed: 30510370
Am J Psychiatry. 1974 Oct;131(10):1121-3
pubmed: 4416585
Braz J Med Biol Res. 1983 Oct;16(3):215-8
pubmed: 6652293